Acacia ferruginea Inhibits Tumor Progression by Regulating Inflammatory Mediators-(TNF-α, iNOS, COX-2, IL-1β, IL-6, IFN-γ, IL-2, GM-CSF) and Pro-Angiogenic Growth Factor-VEGF

  • Published : 2013.06.30


The aim of the present investigation was to evaluate the effect of A ferruginea extract on Dalton's lymphoma ascites (DLA) induced tumours in BALB/c mice. Experimental animals received A ferruginea extract (10 mg/kg.b.wt) intraperitoneally for 14 consecutive days after DLA tumor challenge. Treatment with extract significantly increased the life span, total white blood cell (WBC) count and haemoglobin (Hb) content and decreased the level of serum aspartate transaminase (AST), alanine transaminase (ALT), alkaline phosphatase (ALP), gamma glutamyl transferase (${\gamma}$-GT) and nitric oxide (NO) in DLA bearing ascites tumor models. In addition, administration of extract significantly decreased the tumour volume and body weight in a DLA bearing solid tumor model. The levels of pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-${\alpha}$), interleukin-1 beta (IL-$1{\beta}$), interleukin-6 (IL-6) and granulocyte monocyte-colony stimulating factor (GM-CSF), as well as pro-angiogenic growth factors such as vascular endothelial growth factor (VEGF) and inducible nitric oxide synthase (iNOS) were elevated in solid tumour controls, but significantly reduced by A ferruginea administration. On the other hand, the extract stimulated the production of interleukin-2 (IL-2) and interferon-gamma (IFN-${\gamma}$) in animals with DLA induced solid tumours. Increase in $CD4^+$ T-cell population suggested strong immunostimulant activity for this extract. GC/MS and LC/MS analysis showed quinone, quinoline, imidazolidine, pyrrolidine, cyclopentenone, thiazole, pyrazole, catechin and coumarin derivatives as major compounds present in the A ferruginea methanolic extract. Thus, the outcome of the present study suggests that A ferruginea extract has immunomodulatory and tumor inhibitory activities and has the potential to be developed as a natural anticancer agent.


  1. Araujo JR, Goncalves P, Martel F (2011). Chemopreventive effect of dietary polyphenols in colorectal cancer cell lines. Nutr Res, 31, 77-87.
  2. Bachaya HA, Iqbal Z, Khan MN, et al (2009). Anthelmintic activity of Ziziphus nummularia (bark) and Acacia nilotica (fruit) against Trichostrongylid nematodes of sheep. J Ethnopharmacol, 123, 325-9.
  3. Balunas MJ, Kinghorn D (2005). Drug discovery from medicinal plants. Life Sci, 78, 431-41.
  4. Bukhari IA, Khan RA, Gilani AH, et al (2010). Analgesic, antiinflammatory, and anti-platelet activities of the methanolic extract of Acacia modesta leaves. Inflammopharmacol, 18, 187-96.
  5. Chaubal R, Mujumdar AM, Puranik VG, et al (2003). Isolation and X-ray study of an anti-inflammatory active androstene steroid from Acacia nilotica. Planta Med, 69, 287-8.
  6. Chen Z, Malhotra PS, Thomas GR, et al (1999). Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Clin Cancer Res, 5, 1369-79.
  7. Das SN, Janardhanan KP, Roy SC (1983). Some observations on the ethnobotany of the tribes of totopara and adjoining areas in jalpaiguri district, West Bengal. J Econ Tax Bot, 4, 453-74.
  8. Dinarello CA (1996). Biological basis for interleukin-1 in disease. Blood, 87, 2095-147.
  9. Dongmo AB, Nguelefack T, Lacaille-Dubois MA (2005). Antinociceptive and anti-inflammatory activities of Acacia pennata. J Ethnopharmacol, 98, 201-6.
  10. Eldeen IM, Heerden FR, Staden J (2010). In vitro biological activities of niloticane, a new bioactive cassane diterpene from the bark of Acacia nilotica subsp. Kraussiana J Ethnopharmacol, 128, 555-60.
  11. Gasson JC (1991). Molecular physiology of granulocytemacrophage colony-stimulating factor. Blood, 77, 1131-45.
  12. Gaze DC (2007). The role of existing and novel cardiac biomarkers for cardioprotection. Curr Opin Invest Drugs, 9, 711-7.
  13. Green LC, Wagner DA, Glogowski J, et al (1982). Analysis of nitrate, nitrite and [15N]-nitrate in biological fluids. Anal Biochem, 126, 131-8.
  14. Grivennikov SI, Greten FR, Karin M (2010). Immunity, inflammation, and cancer. Cell, 140, 883-99.
  15. Guerra A SH, Malta DJ N, Laranjeira LP M, et al (2011). Anti-inflammatory and antinociceptive activities of indole-imidazolidine derivatives. Int Immunopharmacol, 11, 1816-22.
  16. Harborne JB (1973). A guide to modern techniques of plant analysis. Phytochemical Methods. London, Chapman and Hall, pp 40-96.
  17. Herman S, Zurgil N, Deutsch M (2005). Low-dose methotrexate induces apoptosis with reactive oxygen species involvement in T-lymphocytic cell lines to a greater extent than in monocytic lines. Inflamm Res, 54, 273-80.
  18. Hodek P, Pavel T, Marie S (2002). Flavonoids potent and versatile biologically active compounds interacting with cytochromes. Chemical Biol Inter, 139, 1-14.
  19. Kalaivani T, Mathew L (2011). Free radical scavenging activity from leaves of Acacia nilotica (L.) Wild. ex Delile, an Indian medicinal tree. Food Chem Toxicol, 48, 298-305.
  20. Kim SN, Kim NH, Park YS, et al (2009). 7-Diethy-lamino-3(2-O-benzoxazolyl)-coumarin is a novel microtubule inhibitor with anti-mitotic activity in multi-drug resistant cancer cells. Biochem Pharmacol, 77, 1773-9.
  21. Lawrence T (2007). Inflammation and cancer: a failure of resolution? Trends in Pharmacol Sci, 28, 162-5.
  22. Lazar ME, Toth S, Falus A (2000). Autocrine and paracrine regulation by cytokines and growth factors in melanoma. Cytokine, 12, 547-54.
  23. Loganayaki N, Manian S (2012). Antitumor activity of the methanolic extract of Ammannia baccifera L. against Dalton's ascites lymphoma induced ascitic and solid tumors in mice. J Ethnopharmacol, 142, 305-9.
  24. Lopes V, Moraes R, Araujo B (2009). Physicochemical and anti-fungal properties of protease inhibitors from Acacia plumosa. Phytochem, 70, 871-9.
  25. Mahato R, Tai W, Cheng K (2011). Pro-drugs for improving tumor targetability and efficiency. Adv Drug Deliv Rev, 63, 659-70.
  26. Mantovani A, Allavena P, Sica A, et al (2008). Cancer-related inflammation. Nature, 454, 436-44.
  27. Meena PD, Kaushik P, Shukla S, et al (2006). Anti-cancer and anti-mutagenic properties of Acacia nilotica (Linn.) on 7,12-dimethylbenz(a) anthracene-induced skin papillomagenesis in Swiss albino mice. Asian Pac J Cancer Prev, 7, 627-32.
  28. Monga J, Chauhan CS, Sharma M (2012). Human breast adenocarcinoma cytotoxicity and modulation of 7, 12-Dimethylbenz [a] anthracene-Induced Mammary Carcinoma in Balb/c Mice by Acacia catechu (Lf) wild heartwood. Integr Cancer Ther, 10, 1177.
  29. Mutai C, Bii C, Vagias C, et al (2009). Anti-microbial activity of Acacia mellifera extracts and lupane triterpenes. J Ethnopharmacol, 123, 143-8.
  30. Nualsanit T, Rojanapanthu P, Gritsanapan W, et al (2012). Damnacanthal, a noni component, exhibits antitumorigenic activity in human colorectal cancer cells. J Nutr Biochem, 23, 915-23.
  31. Rajanna D, Rajkumar MH, Sringeswara AN (2011). Ex-situ conservation of medicinal plants at university of agricultural sciences, Bangalore. Recent Res in Sci and Tech, 13, 3-4.
  32. Rajbir S, Singh B, Singh S, et al (2010). Umbelliferone - An anti-oxidant isolated from Acacia nilotica (L.) Willd. Ex. Del. Food Chem, 120, 825-30.
  33. Ruttimann J (2007). Macrophages and nitric oxide: a deadly combination. J Exp Med, 204, 3057.
  34. Sakthivel KM, Kannan N, Angeline A, et al (2012). Anticancer activity of acacia nilotica (L.) Wild. Ex. Delile Subsp. indica against Dalton's ascitic lymphoma induced solid and ascitic tumor model. Asian Pac J Cancer Prev, 13, 3989-95.
  35. Seigler DS (2003). Phytochemistry of Acacia sensulato. Biochem Syst Ecol, 31, 845-73.
  36. Shi,C, Xu M J, Bayer M, et al (2010). Phenolic compounds and their anti-oxidative properties and protein kinase inhibition from the Chinese mangrove plant Laguncularia racemosa. Phytochemistry, 71, 435-42.
  37. Singh R, Singh S, Kumar S, et al (2006). Studies on antioxidant potential of methanol extract/fractions of Acacia auriculiformis A. Cunn Food Chem, 103, 505-11.
  38. Song KS, Lee WJ, Chung KC, et al (2003). Interleukin-1 beta and tumor necrosis factor-alpha induce MUC5AC overexpression through a mechanism involving ERK/p38 mitogen-activated protein kinases-MSK 1-CREB activation in human airway epithelial cells. J Biol Chem, 278, 243-50.
  39. Sung JY, Hong JH, Kang HS, et al (2000). Methotrexate suppresses the IL-6-induced generation of reactive oxygen species in the synoviocytes of rheumatoid arthritis. Immunopharmacol, 47, 35-44.
  40. Suresh G, Rao JV (1999). Intercropping sorghum with nitrogen fixing trees in semiarid India. Agroforestry Systems, 92, 181-94.
  41. Suzuki A, Takahashi T, Nakamura K, et al (1992). Thrombocytosis in patients with tumors producing colony-stimulating factor. Blood, 80, 2052-9.
  42. Szasz G, Gerhardt W, Gruber EB (1976). Creatinine kinase in serum. Interference of adenylate kinase with the assay. Clin Chem, 22, 1806-12.
  43. Theze J, Alzari PM, Bertoglio J (1996). Interleukin 2 and its receptors: recent advances and new immunological functions. Immunol Today, 18, 487-92.
  44. Trachootham D, Alexandre J, Huang P (2009). Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov, 8, 579-91.
  45. Tung YT, Wu JH, Hsieh CY, et al (2008). Free radical-scavenging phytochemicals of hot water extracts of Acacia confusa leaves detected by an on-line screening method. Food Chem, 115, 1019-24.
  46. Vinod Prabhu V, Guruvayoorappan C (2012). Anti-inflammatory and anti-tumor activity of marine mangrove Rhizophora apiculata. J Immunotoxicol, 9, 341-52.
  47. Weydert CJ, Zhang Y, Sun W, et al (2008). Increased oxidative stress created by adenoviral MnSOD or CuZnSOD plus BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea) inhibits breast cancer cell growth. Free Radic Biol Med, 44, 856-67.
  48. Yue DF, Wang JR (2011). Research progress of the natural products against prostate cancer. Chinese J Nat Med, 9, 81-9.
  49. Zhang H, Forman HJ (2009). Redox regulation of γ-glutamyl transpeptidase. Am J Respir Cell Mol Biol, 41, 509-15.
  50. Zhao CR, Gao ZH, Qu XJ (2010). Nrf2-ARE signaling pathway and natural products for cancer chemoprevention. Cancer Epidemiol, 34, 523-33.
  51. Ziech D, Anestopoulos I, Hanafi R, et al (2012). Pleiotrophic effects of natural products in ROS-induced carcinogenesis: The role of plant-derived natural products in oral cancer chemo-prevention. Cancer Lett, 327, 16-25.

Cited by

  1. Arsenic sulfide as a potential anti-cancer drug vol.11, pp.2, 2014,
  2. Metabolomics Investigation of Cutaneous T Cell Lymphoma Based on UHPLC-QTOF/MS vol.15, pp.13, 2014,
  3. Inhibition Effects of Lamellarin D on Human Leukemia K562 Cell Proliferation and Underlying Mechanisms vol.15, pp.22, 2014,
  4. inhibits cyclophosphamide-induced immunosuppression and urotoxicity by modulating cytokines in mice vol.12, pp.2, 2015,
  5. Synergistic mediation of tumor signaling pathways in hepatocellular carcinoma therapy via dual-drug-loaded pH-responsive electrospun fibrous scaffolds vol.3, pp.17, 2015,
  6. Phytochemical profile and free radical nitric oxide (NO) scavenging activity of Averrhoa bilimbi L. fruit extract vol.7, pp.1, 2017,
  7. A Novel Prognostic Scoring System Using Inflammatory Response Biomarkers for Esophageal Squamous Cell Carcinoma vol.42, pp.1, 2018,
  8. Suppressive effects of acetone extract from the stem bark of three Acacia species on nitric oxide production in lipopolysaccharide-stimulated RAW 264.7 macrophage cells vol.6, pp.8, 2016,
  9. Wogonoside alleviates inflammation induced by traumatic spinal cord injury by suppressing NF-κB and NLRP3 inflammasome activation vol.14, pp.4, 2017,